Dopamine and iron induce apoptosis in PC12 cells

Pharmacology and Toxicology

Volumn 80, Issue 2, 1997, Pages 76-84

  Velez Pardo, Carlos ^a   Del Rio, Marlene Jimenez ^b   Verschueren, Hendrik ^b   Ebinger, Guy ^a   Vauquelin, Georges ^c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CELL PROTEIN; CYTOPLASM PROTEIN; DOPAMINE; FERROCENE; IRON;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MEMBRANE; CATTLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG PROTEIN BINDING; LIPID PEROXIDATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA; BOS TAURUS;

EID: 0031048254     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00287.x     Document Type: Article

References (71)

1. Batistatou, A. & L. Green: Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol. 1991, 115, 461-471.
2. Ben-Shachar, D. & M. B. H. Youdim: Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 1991, 57, 2133-2135.
3. Ben-Shachar, D., R. Zuk & Y. Glinka: Dopamine neurotoxicity: Inhibition of mitochondrial respiration. J. Neurochem. 1995, 64, 718-723.
4. Braghler, J. M., L. A. Duncan & R. L. Chase: The involvement of iron in lipid peroxidation. J. Biol. Chem. 1986, 261, 10282-10289.
5. Brunmark, A. & E. Cadenas: Redox and addition chemistry of quinoid compounds and its implications. Free Rad. Biol. Med. 1989, 7, 435-477.
6. Byrd, J. C. & U. Lichti: Two types of transglutaminases in the PC12 Pheochromocytoma cell line. J. Biol. Chem. 1987, 262, 11699-11705.
7. Carlsson, A. & B. Fornstedt: Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of parkinson's disease. Neurology 1991, 41, 50-51.
8. Dexter, D. T., C. J. Carter, F. R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner & C. D. Marsden: Basal lipid peroxidation in substantia nigra is increased in parkinson's disease. J. Neurochem. 1989, 52, 381-389.
9. Dexter, D. T., A. Carayon, F. Javoy-Agid, Y. Agid, F. R. Wells., S. E. Daniel, A. J. Lees, P. Jenner & C. D. Marsden: Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 1991, 114, 1953-1975.
10. Fahn S. & G. Cohen: The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 1992, 32, 804-812.
11. Fesus, L., V. Thomazy & A. Falus: Induction and activation of tissue Transglutaminase during programmed cell death. FEBS. 1987, 224, 104-108.
12. Folk, J. E.: Transglutaminases. Ann. Rev. Biochem. 1980, 49, 517-531.
13. Fornstedt, B., E. Rosengren & A. Carlsson: Occurrence and distribution of 5-S-cysteynil derivatives of dopamine, dopa and dopac in the brain of eight mammalian species. Neuropharmacol. 1986, 25, 451-454.
14. Gerlach, M., D. Ben-Shachar, P. Riederer & M. B. H. Youdim: Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J. Neurochem. 1994, 63, 793-807.
15. Graham, D. G.: Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 1978, 14, 633-643.
16. Graham, D. G., S. M. Tiffany, W. R. Bell, Jr. & W. F. Gutknecht: Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine,6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 1978, 14, 644-.
17. Greene, L. A. & A. S. Tischler: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 1976, 73, 2424-2428.
18. Griffith, W. & A. Meister: Potent and specific inhibition of glutathione syntesis by buthionine sulfoximine (S-R-Butyl homocysteine sulfoximine). J. Biol. Chem. 1979, 254, 7558-7560.
19. Halliwell, B. & J. M. C. Gutterridge: Lipid peroxidation: A radical chain reaction. In: Free radicals in biology and medicine. Clarendon Press, Oxford, 1989, pp. 188-276.
20. Halliwell, B. & O. I. Aruoma: DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS 1991, 281, 9-19.
21. Halliwell, B.: Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 1609-1623.
22. Heikkila, R. E. & G. Cohen: 6-hydroxydopamine: evidence for superoxide radical as an oxidantive intermediate. Science 1973, 181, 456-457.
23. Ito, S., T. Kato & K. Fujitta: Covalent bindimg of catechols to proteins through the sulphydryl group. Biochem. Pharmacol. 1988, 37, 1707-1710.
24. Jenner, P. G.: Oxidative stress as a cause of Parkinson's disease. In: Neurodegeration. Eds.: Hunter A. J. and M. Clark. Academic Press, London, 1992, pp. 1-20.
25. Jimenez, Del Rio M., J. Pinxteren, W. P. De Potter, G. Ebinger & G. Vauquelin: Serotonin-binding proteins in the bovine cerebral cortex: interaction with serotonin and catecholamines. Eur. J. Pharmacol. 1992, 225, 225-234.
26. Jimenez, Del Rio M., J. Pinxteren, W. P. De Potter, G. Ebinger & G. Vauquelin: Serotonin-binding proteins in the bovine retina: binding of serotonin and catecholamines. Neurochem. Internat. 1993a, 22, 111-119.
27. Jimenez, Del Rio M., C. Velez-Pardo, J. Pinxteren, W. De Potter, G. Ebinger & G. Vauquelin: Binding of serotonin and dopamine to 'serotonin binding proteins' in bovine frontal cortex: evidence for iron-induced Oxidative mechanisms. Eur. J. Pharmacol. 1993b, 247, 11-21.
28. Jimenez, Del Rio M., C. Velez-Pardo, J. Pinxteren, W. De Potter, G. Ebinger & G. Vauquelin: Interaction of serotonin- and dopamine related neurotoxins with "serotonin binding proteins" in bovine frontal cortex. Biochem. Pharmacol. 1994, 48, 253-258.
29. Jimenez, Del Rio M., C. Velez-Pardo, G. Ebinger & G. Vauquelin: Serotonin binding proteins "SBP": Target proteins and tool for in vitro neurotoxicity studies. Gen. Pharmac. 1995, 26, 1633-1641.
30. Kerr, J. F. R., A. H. Wyllie & A. R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
31. Korge, P. & K. Campbel: The effect of change in iron redox state on the activity of enzymes sensitive to modification of SH groups. Arch. Biochem. Biophys. 1993, 304, 420-428.
32. Laemmli, U. K: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
33. Langston, J. W., I. Irwin & G. A. Ricaurte: Neurotoxins, Parkinsonism and Parkinson's Disease. Pharmac. Ther. 1987, 32, 19-49.
34. Lowry, O. H., N. J. Rosebrough, A. C. Farr & R. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
35. MacDonald, E. & J. Sirvio: Neurotoxins as tools in lesioning experiments. In Natural and synthetic neurotoxins. Eds.: A. L. Harvey. Academic Press, Oxford, 1993, pp. 1-46.
36. McGahon, A. J., S. J. Martin , R. P. Bissonnette, A. Mahboubi, Y. Shi, R. J. Mogil, W. K. Nishioka & D. R. Green: The end of the (cell) line: methods for the study of apoptosis in vitro. In: Methods in Cell Biology 46 Cell Death. Eds: L. M. Schwartz & B. A. Osborne. Academic Press, London, 1995, pp. 153-185.
37. 3H]norepinephrine with particulate fractions of cells responsive to catecholamines. Mol. Pharmacol. 1974, 10, 563-581.
38. Martin, S. J., Green D. R. & T. Cotter Dicing with death: dissecting the components of the apoptosis machinery. TIBS, 1994, 19, 26-30.
39. Meister, A.: Selective modification of glutathione metabolism. Science. 1983, 220, 472-477.
40. Meister, A.: Glutathione metabolism and its selective modification. J. Biol. Chem. 1988, 263, 17205-17208.
41. Mesner, P. W., T. R. Winters & S. H. Green: Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 1992, 119, 1669-1680.
42. Mirabelli, F., M. A. Salis, B. Marinoni, G. Finardi, G. Bellono, H. Thor & S. Orrenius: Menadione induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin. Arch. Biochem. Biophys. 1988, 264, 261-269.
43. Michel, P.P & F. Hefti: Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 1990, 26, 428-435.
44. Mohanakumar, K. P., A. De Bartolomeis, R.-M Wu., K. J. Yeh, L. M. Sternberger, S.-Y. Peng, D. L. Murphy & C. C. Chiueh: Ferrous-citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N. Y. Acad. Sci. 1994, 738, 392-399.
45. Montine, T. J., D. B. Farris & D. G. Graham: Covalent crosslinking of neurofilament proteins by oxidised catechol as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 1995, 54, 311-319.
46. Mytilineou, C., S-H. Han & G. Cohen: Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 1993, 61, 1470-1478.
47. Oberhammer, F., J. W. Wilson, C. Dive, I. D Morris, J. A. Hickman, A. E. Wakeling, P. R. Walker & M. Sikorska: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBOJ. 1993, 12, 3679-3684.
48. 2+ dependent mechanism of cytotoxicity and programmed cell death. Toxicol. Lett. 1992, 64/65, 357-364.
49. Pardo, B., M. A. Mena, S. Fahn & J. Garcia de Yebenes: Ascorbic acid protects against levodopa-indued neurotoxicity on a catecholamine-rich human neuroblastoma cell line. Mov. Dis. 1993, 8, 278-284.
50. Pileblad, E. & T. Magnusson: Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-One. Life Sci. 1990, 47, 2333-2342.
51. 2+ and L-Arginine/NADPH. Ann. N.Y. Acad. Sci. 1994, 738, 141-152.
52. Riederer, P., E. Sofic, W-D. Rausch, B. Schmidt, G. P. Reynolds, Jellinger K. & M. B. H. Youdim: Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J. Neurochem. 1989, 52, 515-520.
53. Rotman, A., J. W. Daly, C. R. Creveling & X. O. Breakefield: Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells. Biochem. Pharmacol. 1976, 25, 383-388.
54. Sengstock, G. J., C. W. Olanow, A. J. Dunn & G. W. Arendash: Iron induces degeneration of nigrostriatal neurons. Brain Res. Bullet. 1992, 28, 645-649.
55. Sofic, E., W. Paulus, K. Jellinger, P. Riederer & M. B. H. Youdim: Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 1991, 56, 978-982.
56. Sofic, E., K. W. Lange, K. Jellinger,: Reduced and oxidised glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 1992, 142, 128-130.
57. Spencer, J. P. E., A. Jenner, O. I. Aruoma, P. J. Evans, H. Kaur, D. T. Dexter, P. Jenner, A. J. Lees, D. C. Marsden & B. Halliwell: Intensive oxidative DNA damage by L-DOPA and its metabolites implications for neurodegenerative disease. FEBS Lett. 1994, 353, 246-250.
58. Stadtman, E. R.: Metal ion catalysed oxidation of proteins: biochemical and biological consequences. Free Radical Biol. Med. 1990, 9, 315-325.
59. Streeter, A. J., P. J. Harvison, S. D. Nelson & T. A. Baillie: Crosslinking of protein molecules by the reactive metabolite of acetaminophen, N-acetyl-p-benzoquinone inline, and related quinoid compounds. Adv. Exp. Med. Biol. 1986, 197, 727-737.
60. Tanaka, M., Sotomatsu A., Kanai H. & S. Hirai: Dopa and dopamine cause cultured neuronal death in presence of iron. J. Neurol. Sci. 1991, 101, 198-203.
61. Vauquelin, G., M. Jimenez Del Rio & C. Velez-Pardo: Serotonin binding Proteins: An in vitro model system for monoamine-related neurotoxicity. Ann. NY. Acad. Sci. 1994, 738, 408-418.
62. 2+- mediated binding of serotonin and dopamine to skeletal muscle actin: resemblance to serotonin binding proteins. Eur. J. Pharmacol. 1995a, 288, 209-218.
63. Velez-Pardo, C., M. Jimenez Del Rio, G. Ebinger & G. Vauquelin: Manganese and Copper promote the binding of dopamine to "serotonin binding proteins" in bovine frontal cortex. Neurochem. Int. 1995b, 26, 615-622.
64. Velez-Pardo, C., M. Jimenez Del Rio, G. Ebinger & G. Vauquelin: Redox cycling activity of monoamine- "Serotonin Binding Protein" conjugates. Biochem. Pharmacol. 1996, 51, 1521-1525.
65. Walker, P. R., L. Kokileva, J. LeBlanc & M. Sikorska: Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques 1993, 15, 1032-1036.
66. Walkinshaw, G. & C. M. Waters: Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neurosci. 1994, 63, 975-987. Walkinshaw G. & C. M. Waters: Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implication for the treatment of Parkinson's disease. J. Clin. Invest. 1995, 95, 2458-2464.
67. Walkinshaw, G. & C. M. Waters: Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neurosci. 1994, 63, 975-987. Walkinshaw G. & C. M. Waters: Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implication for the treatment of Parkinson's disease. J. Clin. Invest. 1995, 95, 2458-2464.
68. Ward, R. J., A. L. Florence, D. Baldwin, C. Abiaka, F. Roland, M.H. Ramsey, D. P. E. Dickson, T. J. Peters & R. R. Crichton: Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis. Eur. J. Biochem. 1991, 202, 405-410.
69. Wayner, D. D. M., G. W. Burton & K. U. Ingold: The antioxidant efficiency of vitamine C is concentration-dependent. Bichim. Biophys. Acta 1986, 884, 119-123.
70. Wyllie, A. H.: Glucocorticoid-induce thymocyte apoptosis associated with endogenous endonuclease activation. Nature 1980, 284, 555-556.
71. Youdim, M. B. & P. Riederer: The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J. Neural. Transm. Suppl. 1993, 40, 57-67.